title: 2015 Oman Heart Association guidelines for the management of hypertension : practical recommendations from the Oman Heart Association (OHA).
abstract: Hypertension (HTN) is a major independent risk factor for the development of stroke, coronary artery disease (CAD), peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD). HTN is a growing public health problem in Oman, almost certainly the most prevalent modifiable risk factor for cardiovascular disease (CVD). The risk of CVD in patients with HTN can be greatly reduced with lifestyle modifications and effective antihypertensive therapy. Randomized trials have shown that blood pressure (BP) lowering produces rapid reductions in CV risk. Several studies have shown that the majority of the hypertensive patients remain uncontrolled. It is well established that the observed poor control of the disease is not only related to poor adherence to medications, but also to limited awareness and adherence to evidence-based management of hypertension among physicians. Several guidelines for the management of patients with hypertension have been published. However, the aim of this document is to provide the busy physicians in Oman with more concise and direct approach towards implementing these guidelines into clinical practice.
authors.affiliation: Ministry of Health, Muscat, Sultanate of Oman, deebcardio@hotmail.com.
authors.forename: Mohammed H
authors.initials: MH
authors.lastname: El-Deeb
authors.forename: Kadhim J
authors.initials: KJ
authors.lastname: Sulaiman
authors.forename: Abdullah A
authors.initials: AA
authors.lastname: Al-Riyami
authors.forename: Nabil
authors.initials: N
authors.lastname: Mohsin
authors.forename: Mohamed
authors.initials: M
authors.lastname: Al-Mukhaini
authors.forename: Mohamed
authors.initials: M
authors.lastname: Al-Lamki
authors.forename: Noor
authors.initials: N
authors.lastname: Al-Busaidi
authors.forename: Issa
authors.initials: I
authors.lastname: Al-Salmi
authors.forename: Jawad
authors.initials: J
authors.lastname: Al-Lawati
authors.forename: Najib
authors.initials: N
authors.lastname: Al-Rawahi
authors.forename: Mohamed B
authors.initials: MB
authors.lastname: Al-Riyami
authors.forename: Said
authors.initials: S
authors.lastname: Abdul-Rahman
authors.forename: Said
authors.initials: S
authors.lastname: Al-Hinai
authors.forename: Batool
authors.initials: B
authors.lastname: Jaffer
authors.forename: Ahmed
authors.initials: A
authors.lastname: Al-Wahaebi
authors.forename: Hanan
authors.initials: H
authors.lastname: Al-Khalili
authors.forename: Matllooba
authors.initials: M
authors.lastname: Al-Zadjali
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination / Q000592:standards; D002309:Cardiology / Q000592:standards*; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D009850:Oman / Q000453:epidemiology; D010818:Practice Patterns, Physicians' / Q000592:standards*; D011237:Predictive Value of Tests; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents